Control and drug control groups show normal liver architecture (Figure 3a and 3c). Liver sections treated with CsA produces marked changes like inflammation around portal triad (Triaditis) with patchy microvesicular fatty degeneration (Figure 3b). Sulphated polysaccharides treated rats (Figure 3d) show considerable reduction in the pathological changes compared to CsA-induced animals.<p><b>Copyright information:</b></p><p>Taken from "Role of sulphated polysaccharides from in Cyclosporine A-induced oxidative liver injury in rats"</p><p>http://www.biomedcentral.com/1471-2210/8/4</p><p>BMC Pharmacology 2008;8():4-4.</p><p>Published online 20 Feb 2008</p><p>PMCID:PMC2291455.</p><p></p
